Canada Veterinary Ocular Medicine Market by Supplementary Medications (2024–2032)

Free

in USD Thousand

.js-only{display:none !important;}

Chart preview (first 9 rows), unit: in USD Thousand.

Canada Veterinary Ocular Medicine Market by Supplementary Medications (2024–2032) chart preview

Canada Veterinary Ocular Medicine Market by Supplementary Medications (2024–2032) chart data
Year	Immunomodulators	Anti Glaucoma Agents	Lubricants & Artificial Tears	Mydriatics	Anesthetics & Analgesics
2024	2353.17	1684.6	3059.12	444.3	954.01
2025	2453.46	1727.26	3199	446.77	969.19
2026	2560.74	1772.9	3348.83	449.72	984.29
2027	2677.89	1823.26	3512.47	453.58	1000.08
2028	2809.31	1881.01	3695.82	458.92	1017.78
2029	2960.61	1949.44	3906.46	466.44	1038.8
2030	3139.22	2032.77	4154.48	477	1064.92
2031	3355.04	2136.5	4453.33	491.67	1098.31
2032	3621.19	2267.74	4820.92	511.81	1141.68

Strategic Innovations to Boost Therapeutic Progress in the Canada Veterinary Ocular Medicine Market (2024–2032)

Published by MMR Statistics Reserch Team, November 2025

The Canada veterinary ocular medicine market demonstrated measurable progress in 2024, as immunomodulators recorded USD 2,353.17 thousand and lubricants & artificial tears reached USD 3,059.12 thousand. The steady contribution of anti-glaucoma agents at USD 1,684.60 thousand reflected consistent clinical utilisation in managing ocular disorders among companion animals. This performance underscores the market’s early emphasis on expanding therapeutic diversity and strengthening product portfolios across specialised ophthalmic categories.

In 2025, immunomodulators are estimated to reach USD 2,453.46 thousand, while lubricants & artificial tears are expected to advance to USD 3,199.00 thousand, signalling continued integration into advanced treatment practices. By 2032, lubricants & artificial tears are projected to reach USD 4,820.92 thousand, and immunomodulators are anticipated to attain USD 3,621.19 thousand, outlining a sustained upward trajectory. The Canadian Veterinary Ocular Medicine Market is thus positioned for scalable growth, supported by rising innovation, targeted R&D investments, and expanding adoption of precision-driven ocular therapeutics.

More statistics on Veterinary Ocular Medicine

Related reports

Recommended and recent reports

Subscriptions

Stay ahead of Veterinary Ocular Medicine with tailored access

Sample free-tier statistics or unlock premium coverage for this topic with team-friendly usage rights.

Discover

Try free-tier statistics before committing to a plan.

Start for Free

Professional

Unlock premium coverage across this topic with analyst support.

Select Plan

Contact our team

Need a bespoke deep-dive on Veterinary Ocular Medicine?

Tell us about your KPIs and coverage priorities. We can tailor a briefing, share methodology notes, or build a custom dataset that complements the reports and statistics you are browsing.

Talk with an analyst

Canada Veterinary Ocular Medicine Market by Supplementary Medications (2024–2032)

in USD Thousand

Strategic Innovations to Boost Therapeutic Progress in the Canada Veterinary Ocular Medicine Market (2024–2032)

OTHER STATISTICS ON TOPIC

More statistics on Veterinary Ocular Medicine

Strategic Innovations to Boost Therapeutic Progress in the Canada Veterinary Ocular Medicine Market (2024–2032)

OTHER STATISTICS ON TOPIC

More statistics on Veterinary Ocular Medicine

Download

Download

Recommended and recent reports

Stay ahead of Veterinary Ocular Medicine with tailored access

Need a bespoke deep-dive on Veterinary Ocular Medicine?